Zilla Peter, Bolman R Morton, Boateng Percy, Sliwa Karen
Christian Barnard Department for Cardiothoracic Surgery, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
Anschutz Medical Campus, University of Colorado Denver, Aurora and University of Colorado, Denver, CO, USA.
Cardiovasc Diagn Ther. 2020 Apr;10(2):336-349. doi: 10.21037/cdt.2019.11.03.
Currently, more than five times more people live in low- and middle-income countries (LMICs) than in high-income countries (HICs). As such, the downward trend in cardiac surgical needs in HICs reflects only the situation of one sixth of the world population while the vast majority living in LMICs has still no or limited access to life saving heart operations. In these countries, rheumatic heart disease (RHD) still accounts for a significant proportion of cardiac surgical needs. In low- and lower-middle income countries it remains the single most common cardiovascular disease in young adult and adolescent patients in need of heart surgery outweighing other indications such as congenital cardiac defects almost 4-fold. Compared to HICs with their predominance of calcific aortic stenosis in the elderly mitral valve surgery is required in >90% of the largely young patients with RHD in low-income countries (LICs) and still in 70% of the often middle aged patients in middle-income countries (MICs). Although recent government initiatives in LICs led to the establishment of local, independent cardiac surgical services gradually replacing fly-in missions, these centers still only cover less than 2% of the needs of their populations. In MICs, cardiac surgical needs continually grow with the emergence of degenerative diseases. As such, in spite of the concomitant growth of cardiac surgical capacity, significantly less than half the estimated patients in need have access. Capacities in LICs range from 0.5 to 7 cardiac operations/million population; 100-481/million in MICs and >1,200/million in HICs such as the USA and Germany. While a new level of awareness of the scope and magnitude of the problem has begun to emerge in LICs and the establishment of local cardiac surgical capacity has given rise to a glimpse of hope, the challenges of expanding these fledgling services to a significant proportion of the population still seem insurmountable. Challenges in MICs are on the other hand the widening gap between private cardiac medicine for the affluent few and overwhelmed public services for the many and the rural urban divide with the underappreciation of the ongoing dominance of RHD in the rural and indigent population on the other. Overshadowing all LMICs is the low level of valve-repair skills associated with insufficient cardiac surgical capacity and the unavailability of suitable replacement valves which address the young age of the patients and the difficulties of anticoagulation in a socioeconomic environment distinctly different from the elderly patients of HICs.
目前,生活在低收入和中等收入国家(LMICs)的人口比高收入国家(HICs)多五倍以上。因此,高收入国家心脏外科需求的下降趋势仅反映了世界六分之一人口的情况,而绝大多数生活在低收入和中等收入国家的人仍然无法或只能有限地获得挽救生命的心脏手术。在这些国家,风湿性心脏病(RHD)在心脏外科需求中仍占很大比例。在低收入和中低收入国家,它仍然是年轻成人和青少年心脏手术患者中最常见的心血管疾病,比先天性心脏缺陷等其他病症多出近四倍。与以老年人钙化性主动脉瓣狭窄为主的高收入国家相比,低收入国家(LICs)超过90%的风湿性心脏病年轻患者需要进行二尖瓣手术,在中等收入国家(MICs),这一比例在经常接受手术的中年患者中仍为70%。尽管低收入国家政府最近采取了一些举措,导致当地建立了独立的心脏外科服务,逐渐取代了外来医疗团队,但这些中心仍只能满足不到2%的人口需求。在中等收入国家,随着退行性疾病的出现,心脏外科需求持续增长。因此,尽管心脏外科手术能力随之增长,但仍有不到一半的估计有需求的患者能够获得手术。低收入国家的手术能力为每百万人口0.5至7例心脏手术;中等收入国家为每百万人口100 - 481例,在美国和德国等高收入国家则超过每百万人口1200例。虽然低收入国家对问题的范围和严重程度的认识已开始达到新高度,当地心脏外科手术能力的建立也带来了一丝希望,但将这些初出茅庐的服务扩展到相当一部分人口面临的挑战似乎仍然难以克服。另一方面,中等收入国家面临的挑战包括少数富裕人群的私立心脏医疗与众多人群不堪重负的公共服务之间差距不断扩大,以及城乡差距,农村和贫困人群中风湿性心脏病的持续主导地位未得到充分重视。在所有低收入和中等收入国家中,最突出的问题是瓣膜修复技能水平低,这与心脏外科手术能力不足以及缺乏适合年轻患者的替换瓣膜有关,而且在社会经济环境与高收入国家老年患者截然不同的情况下,抗凝也存在困难。